Adrian Chew

Senior Associate

Adrian specialises in patent related disputes in the biotechnology and pharmaceutical sectors. He regularly advises clients on all issues relating to the enforcement and validity of patents and supplementary protection certificates, including topical issues such as medical use claims, plausibility, antibody functional claims, Article 3 of the SPC Regulation, and the doctrine of equivalents. Adrian also has experience advising clients in contractual disputes involving patent rights.

In addition to proceedings before the English Patents Court and Court of Appeal (such as Teva v Leo, Actavis v Eli Lilly (atomoxetine) and Warner Lambert v NHS England), Adrian has acted in international arbitrations and assisted with matters before the European Patent Office. Adrian also frequently assists clients with coordinating litigation in other jurisdictions, working with law firms in Europe, Korea, India, China and the Middle East. In particular, Adrian advises a top 5 pharmaceutical company in the enforcement of its worldwide patent portfolio for one of its blockbuster drugs.


  • BSc Biology, University College London
  • LLB Law, College of Law
  • Postgraduate Diploma in Intellectual Property Law, Oxford University
  • Qualified 2013

Related Articles